Seventeen patients (58.6%) were taking anticoagulant medications or antiplatelet agents compared to 240 of 506 patients with cSDH (47.4%) indicating a slight trend towards higher frequency, however, did not reach significance concerning rebleeding rate.
← all excerpts
Acute-on-chronic subdural hematoma: a new entity for prophylactic anti-epileptic treatment?
1
—
—